Maravai Lifesciences Holdings Inc Working Capital to Net Assets Ratio
Maravai Lifesciences Holdings Inc working capital to net assets ratio. Maravai Lifesciences Holdings Inc (MRVI) has a Working Capital to Net Assets ratio of 33.0% as of June 2026. Working capital of $117.24 Million (current assets of $155.66 Million minus current liabilities of $38.42 Million) is measured against net assets of $355.59 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Maravai Lifesciences Holdings Inc (MRVI) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Maravai Lifesciences Holdings Inc (2018–2025)
Working capital to net assets ratio of Maravai Lifesciences Holdings Inc from 2018 to 2025. This chart shows how Maravai Lifesciences Holdings Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 33.0%, reflecting working capital of $117.24 Million against net assets of $355.59 Million USD. See defensive interval ratio of Maravai Lifesciences Holdings Inc to measure how many days the company can operate on defensive assets alone.
Maravai Lifesciences Holdings Inc Working Capital to Net Assets Ratio by Year (2018–2025)
Maravai Lifesciences Holdings Inc working capital to net assets ratio by year from 2018 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Maravai Lifesciences Holdings Inc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see MRVI current and non-current assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 67.4% | $251.33 Million | $372.71 Million | $296.25 Million | $44.92 Million | ▲ +3.0 pp |
| 2024 | 64.5% | $372.18 Million | $577.21 Million | $429.15 Million | $56.97 Million | ▼ -13.1 pp |
| 2023 | 77.5% | $612.44 Million | $789.88 Million | $699.91 Million | $87.47 Million | ▼ -4.0 pp |
| 2022 | 81.5% | $737.76 Million | $905.24 Million | $847.90 Million | $110.14 Million | ▼ -37.0 pp |
| 2021 | 118.5% | $646.26 Million | $545.36 Million | $740.04 Million | $93.78 Million | ▼ -11.3 pp |
| 2020 | 129.8% | $200.82 Million | $154.75 Million | $331.60 Million | $130.78 Million | ▲ +108.3 pp |
| 2019 | 21.4% | $30.99 Million | $144.63 Million | $60.55 Million | $29.56 Million | ▲ +9.3 pp |
| 2018 | 12.1% | $17.88 Million | $148.02 Million | $53.80 Million | $35.92 Million | — |